[straight news network reported, Beijing, February 19] (the first pharmacy Caizhi) by cross-border business, industry policy, the decline in passenger traffic and other factors, 2015 drugstore chain terminal health care products sales accounted for appeared different degree of decline. Part of the region is due to health care policy adjustments (health care products for sale), the decline is particularly evident. As the main source of profit of the pharmacy terminal, how to adapt to the current development trend and find a reasonable way to become a pharmacy terminal and health care products manufacturers common proposition.

Three major trends in the future of health care products

One, single product marketing continues to maintain high growth

Although the health needs of economic development to make the sales of health care products pharmacy terminal growing. However, due to the special process of the development of China's health care products, whether it is the practitioner of the pharmacy terminal, or consumers in the market, the lack of scientific knowledge of health care products. And the current rise of health care products marketing, whether it is the degree of difficulty in market education, or the risk of market investment control, it is in line with market rules. So the future of such products in the pharmacy terminal will remain relatively high growth.

1, absolute incremental single product: mainly for the market environment changes and the new health needs. For example, is conducive to the link visual fatigue of lutein products, is for the present "bow family". A similar variety will bring the absolute increment and new profit sources for the pharmacy terminal;

2, upgrade class incremental single product: with the national health care product registration system, the new resource food policy landing, the variety of health care products has entered a substantive stage. The dominant position of the traditional "fish, egg, calcium has ceased to exist, in terminal drugstore, the upgrading of the alternative products continue to show, such as on the antioxidation and protection of cardiovascular function over of coenzyme Q10 and astaxanthin in fish oil, to replace the traditional calcium ammonia sugar products, improve the absorption rate of the protein peptide powder. With the attention of the market and the terminal, sales accounted for all of the increase.

3, the return of the specialized process of incremental single product: with the return of the pharmacy terminal specialization, the clerk's recommendation will be more scientific and reasonable. In particular, chronic disease management process, you can find more prescription drugs + health products, the associated sales opportunities. Ease the side effects of drugs (such as coenzyme Q10 to ease the side effects of statins) and other products will form a new incremental sales.

Two, big health market differentiation intensified

Large health care category in the pharmacy profit contribution beyond doubt. But throughout the country market, to cover the national market, and continue to brand building is very rare. More and more enterprises partial keep a corner, dependence chain pharmacies recommended, to occupy a certain market share, so can judge, 2016 health market will be further divided.

1, the acquisition and integration to promote the reform of the major health care industry. With the full involvement of the capital, the acquisition and integration of health care products industry in the end of 2015 to become the hottest topic. More and more listed pharmaceutical companies (Zhejiang pharmaceutical, pharmaceutical) also began to enter the health care field. These pharmaceutical companies the biggest characteristic is has very powerful channel coverage capabilities and marketing capabilities, and traditional regional brands and small - and medium-sized enterprises (SMEs), because investment in marketing and terminal management is difficult to compete with, if continue to use defensive coping, market will being eroded.

2, traditional Chinese medicine health products will force. The pharmacies terminal sales of health products are mainly Europe and the United States market dietary supplements (SUPPLEMENT), high degree of standardization of these products, with cross-border comprehensive intervention, the existing price system may will be a very big challenge. Because of China's special health care consumer attitudes, some of the traditional "medicine and food homology" series of health food products will be favored by the market. In particular, ginseng, three seven and other Chinese herbal medicines, the consumer will be the new cognition of Chinese medicine and the formation of a new growth point.

3, the rapid sales of the category to form a new growth point. Due to the deepening of the market education, some of the new formulations, packaging differences, unique taste of health food will continue to appear. In particular, the relatively low cost of trial and diversification of the associated sales, will also be in the future pharmacy terminal to form a long tail product group, in order to provide support for the pharmacy terminal to enhance the number of customers.